CEO: Craig Kennedy
MolecuLight is developing a non-invasive optical technology that acquires images in a manner similar to standard point-and-shoot digital cameras. The device provides real-time bacteriological information which is otherwise unobtainable using industry standard wound assessment techniques, including conventional white light visualization. The first application of this technology will be in the global wound care market where there is an urgent medical need and where MolecuLight can significantly improve outcomes by providing rapid and accurate diagnosis.
- News & Insights: How three health IT companies are keeping Ontario healthy